BioCentury | Aug 21, 2006
Company News

Altus management update

...Shire Pharmaceuticals Group plc; and John Sorvillo as VP of business development, formerly CEO of Bionaut Pharmaceuticals Inc. WIR...
BioCentury | Aug 14, 2006
Company News

Altus management update

...Business: Gastrointestinal, Endocrine, Metabolic Hired: John Sorvillo as VP of business development, formerly CEO at Bionaut Pharmaceuticals Inc. WIR...
BioCentury | May 23, 2005
Company News

Bionaut, National Cancer Institute deal

...The parties will collaborate to profile Bionaut's cancer compounds that inhibit the ability of tumors cells...
...inhibit the ability of tumors cells to survive under stress conditions. Also, NCI will test Bionaut's...
...biomarkers that are induced or suppressed. NCI will also test whether Bionaut's compounds suppress metastasis. Bionaut Pharmaceuticals Inc....
BioCentury | Apr 18, 2005
Company News

AnalytiCon, Bionaut deal

...and optimize compounds that inhibit the ability of tumor cells to survive under stress conditions. Bionaut...
...and AnalytiCon will use its natural product and medicinal chemistry capabilities to optimize the compounds. Bionaut...
...System for compound validation. Financial terms were not disclosed. AnalytiCon Discovery GmbH , Potsdam, Germany Bionaut Pharmaceuticals Inc....
BioCentury | Apr 15, 2005
Company News

Bionaut, AnalytiCon in cancer deal

...Bionaut (Cambridge, Mass.) and AnalytiCon Discovery (Potsdam, Germany) partnered to identify and optimize cancer compounds. Bionaut...
BioCentury | Jul 12, 2004
Emerging Company Profile

Corporate Profile

Bionaut Pharmaceuticals Inc. Cambridge, Mass. Technology: Cell-based reporter assay platform Disease focus: Cancer and inflammation Clinical status: Preclinical Founded: 2000 by Mehran Khodadoust and Thomas Klein Corporate partners: AstraZeneca plc ; Biogen Idec Inc. ;...
BioCentury | Jul 12, 2004
Emerging Company Profile

Bionaut: Fast track pathways

...By employing a pathway-based approach to drug discovery, with a focus on cancer and inflammation, Bionaut Pharmaceuticals Inc....
...used to identify new compounds, as well as to find news uses for existing ones, Bionaut...
...drug discovery engine that we can use to develop NCEs." To enter the clinic quickly, Bionaut...
BioCentury | Jul 14, 2003
Company News

Bionaut management update

Bionaut Pharmaceuticals Inc. , Cambridge, Mass. Business: Cancer, Autoimmune/Inflammation Hired: Kees Been as CEO, formerly SVP of the oncology business unit at Biogen Inc. WIR Staff autoimmune cancer Inflammation...
BioCentury | Jul 8, 2003
Company News

Bionaut names Been CEO

...Been as CEO. Prior, he was VP of the oncology business unit at Biogen (BGEN). Bionaut...
Items per page:
1 - 9 of 9
BioCentury | Aug 21, 2006
Company News

Altus management update

...Shire Pharmaceuticals Group plc; and John Sorvillo as VP of business development, formerly CEO of Bionaut Pharmaceuticals Inc. WIR...
BioCentury | Aug 14, 2006
Company News

Altus management update

...Business: Gastrointestinal, Endocrine, Metabolic Hired: John Sorvillo as VP of business development, formerly CEO at Bionaut Pharmaceuticals Inc. WIR...
BioCentury | May 23, 2005
Company News

Bionaut, National Cancer Institute deal

...The parties will collaborate to profile Bionaut's cancer compounds that inhibit the ability of tumors cells...
...inhibit the ability of tumors cells to survive under stress conditions. Also, NCI will test Bionaut's...
...biomarkers that are induced or suppressed. NCI will also test whether Bionaut's compounds suppress metastasis. Bionaut Pharmaceuticals Inc....
BioCentury | Apr 18, 2005
Company News

AnalytiCon, Bionaut deal

...and optimize compounds that inhibit the ability of tumor cells to survive under stress conditions. Bionaut...
...and AnalytiCon will use its natural product and medicinal chemistry capabilities to optimize the compounds. Bionaut...
...System for compound validation. Financial terms were not disclosed. AnalytiCon Discovery GmbH , Potsdam, Germany Bionaut Pharmaceuticals Inc....
BioCentury | Apr 15, 2005
Company News

Bionaut, AnalytiCon in cancer deal

...Bionaut (Cambridge, Mass.) and AnalytiCon Discovery (Potsdam, Germany) partnered to identify and optimize cancer compounds. Bionaut...
BioCentury | Jul 12, 2004
Emerging Company Profile

Corporate Profile

Bionaut Pharmaceuticals Inc. Cambridge, Mass. Technology: Cell-based reporter assay platform Disease focus: Cancer and inflammation Clinical status: Preclinical Founded: 2000 by Mehran Khodadoust and Thomas Klein Corporate partners: AstraZeneca plc ; Biogen Idec Inc. ;...
BioCentury | Jul 12, 2004
Emerging Company Profile

Bionaut: Fast track pathways

...By employing a pathway-based approach to drug discovery, with a focus on cancer and inflammation, Bionaut Pharmaceuticals Inc....
...used to identify new compounds, as well as to find news uses for existing ones, Bionaut...
...drug discovery engine that we can use to develop NCEs." To enter the clinic quickly, Bionaut...
BioCentury | Jul 14, 2003
Company News

Bionaut management update

Bionaut Pharmaceuticals Inc. , Cambridge, Mass. Business: Cancer, Autoimmune/Inflammation Hired: Kees Been as CEO, formerly SVP of the oncology business unit at Biogen Inc. WIR Staff autoimmune cancer Inflammation...
BioCentury | Jul 8, 2003
Company News

Bionaut names Been CEO

...Been as CEO. Prior, he was VP of the oncology business unit at Biogen (BGEN). Bionaut...
Items per page:
1 - 9 of 9